Recommendation for immune prophylaxis of respiratory syncytial virus infection in children

Respiratory syncytial virus (RSV) is the most common pathogen for young children hospitalized with bronchiolitis and pneumonia. Most infections occur below 1 year of age, and almost all children have been infected before 2 years of age.Monoclonal antibodies targeting RSV, such as palivizumab and nir...

Full description

Bibliographic Details

Published in:	Journal of Microbiology, Immunology and Infection
Main Authors:	Ping-Ing Lee, Yhu-Chering Huang, Chih-Jung Chen, Cheng-Hsun Chiu, Po-Yen Chen, Chun-Yi Lu, Ching-Chuan Liu, Nan-Chang Chiu, Hsin Chi, Chien-Yu Lin, Chun Yi Lee, Shuenn-Nan Chiu, Mei-Jy Jeng, Kuang-Che Kuo, Ren-Bin Tang, Yung-Feng Huang, Hui-Hsien Pan, Ming-Fang Cheng, Li-Min Huang, Ya-Li Hu, Tzou-Yien Lin
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Subjects:	respiratory syncytial virus monoclonal antibody palivizumab nirsevimab Prophylaxis
Online Access:	http://www.sciencedirect.com/science/article/pii/S1684118225000404